普通外文研报
Replay and Transcript: Fresenius Medical Care - Barclays Conversations with the C-Suite in European Healthcare 2026
研报英文原文证据摘录
Replay and Transcript: Fresenius Medical Care - Barclays Conversations with the C-Suite in European Healthcare 2026
Equity Research
30 June 2026
Replay and Transcript
Fresenius Medical Care: Barclays
Conversations with the C-Suite in
European Healthcare 2026 European Medical Technology &
Services
US SMTG Q1 softness spilling into Q2, flat growth in 26 still Hassan Al-Wakeel, CFA
expected. PPS draft rate lowest since 21 but within 1-2% co. +44 (0)20 7773 3898
hassan.al-wakeel@barclays.com
base case, could see upward revision. Binders better & could Barclays, UK
come down. Not concerned on Theranova HDF competition, Jonathon Unwin
expect to report only qualitative benefits of HDF in Q2 +44 (0)20 7773 0354 jonathon.unwin@barclays.com
Barclays, UK
Please see below replay information for the event held on Marco+44 (0)20Pires-Cox3134 3421
Monday, 29 June 2026 at 3:00pm – 4:00pm UTC marco.pirescox@barclays.com
This replay is strictly and solely for the benefit of the intended recipients. Barclays Events Terms of
Rohit Rajan Service and the Barclays Events Privacy Notice
+91 (0) 22 6175 1698
rohit.rajan@barclays.com
Watch Barclays, UK
This transcript/recording is provided in an unedited format. Barclays is not responsible for the
recording quality or any transcription errors or omissions.
View Transcript
Appearances by Third-Party Speakers: Any views or opinions expressed by third-party speakers
during this event are solely those of the speaker and do not represent the views or opinions of
Barclays. Barclays is not responsible for, and makes no warranties whatsoever as to, the
information or opinions contained in any written, electronic, audio or video presentations by any
third-party speakers at the event (“Third-Party Content”). Any such Third-Party Content has not
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器